ePoster

ENGINEERING A MULTICELLULAR NEUROIMMUNE COMPETENT HUMAN BRAIN ORGANOID MODEL FOR ALZHEIMER’S DISEASE

Sergio Helgueta Romeroand 9 co-authors

GIGA Neurosciences

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-167

Presentation

Date TBA

Board: PS05-09AM-167

Poster preview

ENGINEERING A MULTICELLULAR NEUROIMMUNE COMPETENT HUMAN BRAIN ORGANOID MODEL FOR ALZHEIMER’S DISEASE poster preview

Event Information

Poster Board

PS05-09AM-167

Abstract

Alzheimer’s disease (AD) is neuropathologically characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles. AD occurs as familial or sporadic (genetic and environmental factors). Increasing evidence highlights microglia as key mediators in AD pathogenesis, with human-specific factors crucial for modeling the disease spectrum, emphasizing the need for improved human models. Here, we optimized a protocol to derive human microglia from pluripotent stem cells (hPSC) through exposure of primitive macrophage precursors (PMPs) to an IGMT cytokine cocktail (IL34, GM-CSF, M-CSF, and TGFβ1) that results in a population with enriched microglial-specific gene expression and typical microglia ramified morphology. In contrast, classical cultures using FBS showed endothelial-like contamination. Transcriptomic analysis revealed upregulated microglial gene signatures, enhanced cytokine response, cytoskeletal reorganization, and extracellular matrix remodeling. Compared to PMPs and H9 hPSCs, IGMT microglia displayed a canonical microglial transcriptome.
Upon exposure to Aβ fibrils, microglia showed higher motility, rapid recruitment, aggregation, and efficient phagocytosis. Transcriptomic profile of Aβ-treated microglia revealed enriched pathways associated with AD, as well as Interferon response, TNF-alfa signaling and mitochondrial-associated pathways. However, phagocytosis capacity, cytoskeleton and extracellular matrix-associated pathways were downregulated, suggesting a state of progressive microglial dysfunction.
We established a human multicellular brain organoid (hmBOs) model that incorporates microglia. Optimal integration and survival was achieved by a combination of PMPs and IGMT cytokines, which led to high neuronal viability and microglial densities comparable to the in vivo cortex.
In conclusion, we developed neuroimmune-competent hmBOs that could serve to study neurodegenerative disorders characterized by an important immune component, such as AD

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.